Pre‐ and Postnatal Development Study of Nemolizumab, a Humanized Anti‐Interleukin‐31 Receptor A Monoclonal Antibody, in Cynomolgus Monkey
Blocking IL-31 signaling with repeated dosing of nemolizumab did not adversely affect pregnancy, parturition, nursing, or postnatal physical and functional development in cynomolgus monkeys.
Authors
- Ryuichi Katagiri (ORCID: https://orcid.org/0000-0002-5481-4064)
- Masanori Sasaki (ORCID: https://orcid.org/0000-0003-3800-3242)
- Saori Matsuo
- Akihiro Arima
- Shuichi Chiba (ORCID: https://orcid.org/0000-0002-5617-4902)
- Akihisa Kaneko (ORCID: https://orcid.org/0000-0002-6558-1892)
- Hisashi Ikegami
Institutions
- Shin Nippon Biomedical Laboratories (Japan) (JP)
Publication Details
- Journal
- Birth Defects Research
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1002/bdr2.2442
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.00